Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise program aims to boost strength and endurance in kids with sickle cell disease

NCT ID NCT06074198

First seen Apr 23, 2026 · Last updated Jun 23, 2026 · Updated 16 times

Summary

This study is testing whether a moderate exercise program can improve strength, balance, and endurance in children with sickle cell disease. Twenty children ages 6 to 17 will take part in strengthening and endurance exercises. Researchers will measure changes in muscle strength, walking ability, and overall exercise tolerance.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Maryland School of Medicine Dept. of Physical Therapy & Rehabilitation Science

    Baltimore, Maryland, 21201-1082, United States

  • University of Maryland, Baltimore

    Baltimore, Maryland, 21201, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

strengthening and endurance exercises

What this could lead to

If successful, this could show that a structured exercise program is safe and helpful for improving physical function in children with sickle cell disease.

What could go wrong

This is a small, early feasibility study with only 20 participants. It may not prove the exercise program works for all children, and results may not apply to those with complications.

Conditions

The condition(s) this trial relates to.

sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.